Safety of Rupatadine Administered Over a Period of 1 Year in the Treatment of Persistent Allergic Rhinitis-Reference-Cited by-同舟云学术

Safety of Rupatadine Administered Over a Period of 1 Year in the Treatment of Persistent Allergic Rhinitis

Published:2009 Issue:1 Volume:32 Page:33-42
ISSN:0114-5916
Container-title:Drug Safety
language:en
Short-container-title:Drug Safety

Author:

Valero Antonio,de la Torre Fernando,Castillo José Antonio,Rivas Pilar,del Cuvillo Alfonso,Antépara Ignacio,Borja Javier,Donado Esther,Molà Oriol,Izquierdo Iñaki

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Toxicology

Reference27 articles.

1. Allergic Rhinitis and Its Impact on Asthma

2. Diagnosis and Management of Rhinitis: Complete Guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology

3. Changing prevalence of allergic rhinitis and asthma

4. Characteristics of intermittent and persistent allergic rhinitis: DREAMS study group

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A single-dose, randomized, open-label, four-period, crossover equivalence trial comparing the clinical similarity of the proposed biosimilar rupatadine fumarate to reference Wystamm® in healthy Chinese subjects;Frontiers in Pharmacology;2024-05-17

2. Applying Artificial Intelligence to Identify Common Targets for Treatment of Asthma, Eczema, and Food Allergy;International Archives of Allergy and Immunology;2023-11-21

3. Efficacy and safety of on‐demand versus daily rupatadine in chronic spontaneous urticaria: A randomized trial;Allergy;2023-08-19

4. Applying Artificial Intelligence to Identify Common Targets for Treatment of Asthma, Eczema, and Food Allergy;2023-07-01

5. The Platelet-Activating Factor Receptor’s Association with the Outcome of Ovarian Cancer Patients and Its Experimental Inhibition by Rupatadine;Cells;2021-09-07